American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Clinical Reasoning Series in Critical Care Pharmacy — Part Two

Monday, November 13, 2023 from 1:00 PM to 4:30 PM CST at Lone Star Ballroom C1


The Clinical Reasoning Series aims to deliver programs that will meaningfully contribute to advancing pharmacy specialists’ knowledge, skills, and clinical judgment. Topic selection for the program reflects content that is timely and of relevance and value to the practice of both Board Certified Critical Care Pharmacists (BCCCP) and Board Certified Pharmacotherapy Specialists (BCPS).

Participants will have the opportunity to attend four educational activities, broken into a two-part morning and two-part afternoon session. Part Two will offer 3.0 contact hours of continuing pharmacy education credit toward BCCCP and/or BCPS recertification credit upon completion of a required posttest by the submission deadline and achievement of a predetermined passing score. The posttest will be available on December 12, 2023. The deadline to submit posttests and earn recertification credit for the session will be December 12, 2024. If you have not already purchased the posttest and wish to add it to your registration, email [email protected] or visit the registration desk on or before November 14, 2023.

Faculty

Audrey J. Jones, Pharm.D.,  MBA, BCCCPModerator: Audrey J. Jones, Pharm.D., MBA, BCCCP
Title: Clinical Reasoning Series in Critical Care Pharmacy — Part Two
Institution: Cleveland Clinic Foundation
City/State: Cleveland Heights, OH

Anticoagulant Monitoring for Patients in the Critically Ill Setting & Perioperative Management of the Bleeding Patient ​​

1:00 PM to 4:30 PM

Available for 3.00 hours of CPE credit
Activity Number: 0217-0000-23-098-L01-P
Activity Type: An Application-Based Activity

With the role of viscoelastic testing in patients with acute bleed evolving, pharmacists will play a vital part in managing anticoagulation and factor stewardship at many institutions. During this two-part presentation, Speakers will address pharmacotherapeutic management strategies used to prevent and treat a bleeding patient, and the need for pharmacists to be updated on interpreting these systems and how they can best guide treatment. This learning activity will focus on the role of a pharmacist in guiding hemostasis and monitoring of anticoagulants in the intensive care unit and within the perioperative period. In addition, many patients with bleeding disorders may require alternative anticoagulant monitoring due to discordant laboratory markers, and Part Two of this Clinical Reasoning Series will address such.



There will be scheduled breaks between presentations from: 2:00—2:15 p.m., and 3:15—3:30 p.m.


Gianna Lauren H. Casal, Pharm.D., BCCCPSpeaker: Gianna Lauren H. Casal, Pharm.D., BCCCP
Title: Anticoagulant Monitoring for Patients in the Critically Ill Setting & Perioperative Management of the Bleeding Patient ​​
Institution: Massachusetts General Hospital
City/State: Cambridge, MA
  View Biography
Corey J. Witenko, Pharm.D., FCCM, BCCCP, BCPSSpeaker: Corey J. Witenko, Pharm.D., FCCM, BCCCP, BCPS
Title: Anticoagulant Monitoring for Patients in the Critically Ill Setting & Perioperative Management of the Bleeding Patient ​​
Institution: Theravance Biopharma
City/State: New York, NY
  View Biography

Learning Objectives
1. Analyze standard anticoagulation monitoring to identify patients that may warrant alternative assessments.
2. Distinguish between discordant laboratory markers to ensure appropriate anticoagulant monitoring.
3. Propose an individualized anticoagulation monitoring plan based on interacting disease states.
4. Identify barriers to implementing alternative anticoagulant assays.
5. Assess pharmacotherapeutic management strategies to prevent and treat bleeding in perioperative patients with a history of antithrombotic use or an inherited bleeding disorder.
6. Interpret viscoelastic testing to formulate a treatment plan for a bleeding patient.
7. Appraise the current literature surrounding blood factor stewardship and its impact on patient outcomes and the pharmacy department.

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.